My Profile
Agnes Crane
Making a market in
Ideas
See all posts
Sun 29 Nov 2009 | 8:30 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Qiagen N.V.
Qiagen N.V. (QGEN.O) (Nasdaq)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
QGEN
on other exchanges
As of 27 Nov 2009
21.97
USD
Price Change
+0.02
Percent Change
+0.09%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Total Annual Compensation
Long-Term Incentive Plans
All Other
Fiscal Year Total
As Of 30 Dec 2007
Brandt, Werner
16,500
--
3,700
21,450
Claussen, Carsten
--
--
--
--
Collasius, Michael
--
--
--
--
Colpan, Metin
20,000
--
7,300
27,300
Hornnaess, Erik
30,000
--
7,300
43,550
Karobath, Manfred
20,000
--
7,300
29,800
Liu, Douglas
--
--
--
--
Riesner, Detlev
36,000
--
7,300
45,800
Sackers, Roland
452,000
--
215,000
667,000
Schatz, Peer
1,059,000
--
448,000
1,507,000
Schorr, Joachim
291,000
--
149,000
440,000
Schriek, Ulrich
--
--
--
--
Schweins, Thomas
--
--
--
--
Uder, Bernd
311,000
--
141,000
452,000
Von Prondzynski, Heino
12,000
--
3,700
16,950
Find out more about QGEN.O
Insider Trading